An analysis of several studies finds that the use of radiation therapy after breast-conserving surgery (also called lumpectomy) not only reduces the chances that breast cancer will return but also increases the overall odds of survival in early breast cancer patients. Though the ability of radiation therapy to reduce the recurrence of breast cancer is generally well-known, the fact that survival can improve with radiation therapy is quite promising. This may encourage more early stage breast cancer patients to comply with the standard recommendation
of radiation after lumpectomy.

A new study finds that women who are diagnosed with breast cancer and receive genetic testing to determine their risk of developing cancer in the opposite breast are more likely to choose preventive treatment. Normally, women with breast cancer are given the option of genetic testing after their breast cancer surgery to determine whether they carry mutations of certain genes that put them at greater risk of developing breast cancer in the other breast. However, the current study suggests that performing genetic testing prior to breast cancer surgery can help women make informed decisions about preventive measures.

Researchers have identified a number of factors that can increase a woman's risk of developing breast cancer. Some risk factors (such as age and family history) cannot be changed while other factors (such as lifestyle) can be modified. This article discusses in detail breast cancer risk factors identified by researchers.

Lobular carcinoma in situ (LCIS, also called lobular neoplasia) refers to a sharp increase in the number, appearance, and abnormal behavior of cells contained in the milk-producing lobules of the breast. Though categorized as a stage 0 breast cancer (the earliest stage), LCIS is not considered a cancer. Rather, it is "marker" (a signal) that breast cancer may develop. This article discusses what LCIS is and how women who are diagnosed with LCIS may help prevent breast cancer.